Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Selected Financial Info by Reportable Segment

Selected financial information by reportable segment is presented below (in thousands):

	Three Months Ended March 31,
	2020		2019
Revenues, net:
Prescription Pharmaceuticals	$	179,244	$	148,015
Consumer Health	25,449		17,856
Total revenues, net	204,693		165,871
Gross Profit:
Prescription Pharmaceuticals	77,159		45,443
Consumer Health	17,385		8,070
Total gross profit	94,544		53,513
Operating expenses	341,462		118,996
OPERATING (LOSS)	(246,918)		(65,483)
Other expenses, net	(33,254)		(15,278)
(Loss) before income taxes	$	(280,172)	$	(80,761)

Revenue from External Customers by Geographic Areas

The following table sets forth the Company’s net revenues by geographic region for the three month periods ended March 31, 2020 and 2019. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):

	Three Months Ended March 31, 2020			Three Months Ended March 31, 2019
Region	Amount		% of Total Revenues	Amount		% of Total Revenues
Domestic	$	201,834	98.6%	$	164,134	99.0%
Foreign	2,859		1.4%	1,737		1.0%
Total Revenues	$	204,693	100.0%	$	165,871	100.0%